Comparison between Influx Healthtech IPO and Solvex Edibles IPO.
Influx Healthtech IPO is a SME Fixed Price IPO proposed to list at NSE SME while Solvex Edibles IPO is a SME Fixed Price proposed to list at BSE SME.
| Influx Healthtech IPO | Solvex Edibles IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Rarever Financial Advisors Pvt.Ltd. | Corporate Makers Capital Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | R.K.Stock Holding Pvt.Ltd. | JSK Securities & Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Influx Healthtech IPO is up to ₹55.63 Cr whereas the issue size of the Solvex Edibles IPO is up to ₹17.93 Cr. The final issue price of Influx Healthtech IPO is ₹96.00 per share and of Solvex Edibles IPO is ₹72.00 per share.
| Influx Healthtech IPO | Solvex Edibles IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | |
| Issue Price (Upper) | ₹96.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹72.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1200 shares | 1600 shares |
| Fresh Issue Size | 46,94,400 shares | 24,89,600 shares |
| Fresh Issue Size (Amount) | up to ₹45.07 Cr | up to ₹17.93 Cr |
| OFS Issue Size | 11,00,400 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹10.56 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,94,800 shares | 24,89,600 shares |
| Issue Size Total (Amount) | up to ₹55.63 Cr | up to ₹17.93 Cr |
Influx Healthtech IPO opens on Jun 18, 2025, while Solvex Edibles IPO opens on Sep 22, 2025. The closing date of Influx Healthtech IPO and Solvex Edibles IPO is Jun 20, 2025, and Sep 26, 2025, respectively.
| Influx Healthtech IPO | Solvex Edibles IPO | |
|---|---|---|
| Anchor Bid Date | Jun 17, 2025 | |
| Issue Open | Jun 18, 2025 | Sep 22, 2025 |
| Issue Close | Jun 20, 2025 | Sep 26, 2025 |
| Basis Of Allotment (Tentative) | Jun 23, 2025 | Sep 29, 2025 |
| Initiation of Refunds (Tentative) | Jun 24, 2025 | Sep 30, 2025 |
| Credit of Share (Tentative) | Jun 24, 2025 | Sep 30, 2025 |
| Listing date (Tentative) | Jun 25, 2025 | Oct 01, 2025 |
| Anchor Lockin End date 1 | Jul 23, 2025 | |
| Anchor Lockin End date 2 | Sep 21, 2025 |
Influx Healthtech IPO P/E ratio is 13.04, as compared to Solvex Edibles IPO P/E ratio of 11.15.
| Influx Healthtech IPO | Solvex Edibles IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Influx Healthtech Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 19% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Solvex Edibles Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 305% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.85 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 70.72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.04 | 11.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹222.24 Cr. | ₹64.45 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 36.98% | 23.69% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 49.17% | 24.51% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.36 | ₹6.46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 36.98% | 20.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Influx Healthtech IPO Retail Individual Investors (RII) are offered 20,29,200 shares while in Solvex Edibles IPO retail investors are offered 20,29,200 shares. Qualified Institutional Buyers (QIB) are offered 11,59,200 shares in Influx Healthtech IPO and 0 shares in Solvex Edibles IPO.
| Influx Healthtech IPO | Solvex Edibles IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,36,400 shares | 0 shares |
| Market Maker Reservation | 3,06,000 shares | 1,31,200 shares |
| QIB | 11,59,200 shares | 0 shares |
| NII | 8,70,000 shares | 12,44,800 shares |
| RII | 20,29,200 shares | 12,44,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 57,94,800 shares | 24,89,600 shares |
Influx Healthtech IPO subscribed 201.35x in total, whereas Solvex Edibles IPO subscribed 1.02x.
| Influx Healthtech IPO | Solvex Edibles IPO | |
|---|---|---|
| QIB (times) | 137.87x | |
| NII (times) | 481.10x | 1.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 117.68x | 0.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 201.35x | 1.02x |
